Masimo Corp., an Irvine-based medical device maker amid an executive upheaval, said it has “terminated the employment” of Tom McClenahan, the company’s Executive Vice President, General Counsel and Corporate Secretary, effective as of Feb. 6. No reason was given.
Shareholders at the company voted to oust founder and Chairman Joe Kiani last September after a proxy battle. Kiani later resigned as chief executive as well.
The company hired as CEO Katie Szyman, who is slated to start on Feb. 12. Szyman was previously worldwide president of BD Advanced Patient Monitoring, the former Critical Care Unit of Edwards Lifesciences. Corp.
McClenahan worked at Masimo for almost 14 years, according to his LinkedIn page.
Shares of Masimo were little changed in after-hours trading. During regular trading, they fell 2.1% to $176.16 and a $9.4 billion market cap.